These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 22915767)
21. Pretreatment with statin attenuates the cardiotoxicity of Doxorubicin in mice. Riad A; Bien S; Westermann D; Becher PM; Loya K; Landmesser U; Kroemer HK; Schultheiss HP; Tschöpe C Cancer Res; 2009 Jan; 69(2):695-9. PubMed ID: 19147586 [TBL] [Abstract][Full Text] [Related]
22. Cardioprotection against doxorubicin by metallothionein Is associated with preservation of mitochondrial biogenesis involving PGC-1α pathway. Guo J; Guo Q; Fang H; Lei L; Zhang T; Zhao J; Peng S Eur J Pharmacol; 2014 Aug; 737():117-24. PubMed ID: 24858368 [TBL] [Abstract][Full Text] [Related]
23. Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis. Hao E; Mukhopadhyay P; Cao Z; Erdélyi K; Holovac E; Liaudet L; Lee WS; Haskó G; Mechoulam R; Pacher P Mol Med; 2015 Jan; 21(1):38-45. PubMed ID: 25569804 [TBL] [Abstract][Full Text] [Related]
24. Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Doroshow JH Cancer Res; 1983 Feb; 43(2):460-72. PubMed ID: 6293697 [TBL] [Abstract][Full Text] [Related]
25. Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism. Cusack BJ; Gambliel H; Musser B; Hadjokas N; Shadle SE; Charlier H; Olson RD Cancer Chemother Pharmacol; 2006 Oct; 58(4):517-26. PubMed ID: 16555089 [TBL] [Abstract][Full Text] [Related]
26. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Conklin KA Integr Cancer Ther; 2005 Jun; 4(2):110-30. PubMed ID: 15911925 [TBL] [Abstract][Full Text] [Related]
27. Antioxidant defense against anthracycline cardiotoxicity by metallothionein. Kang YJ Cardiovasc Toxicol; 2007; 7(2):95-100. PubMed ID: 17652812 [TBL] [Abstract][Full Text] [Related]
28. Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH). Sterba M; Popelová O; Simůnek T; Mazurová Y; Potácová A; Adamcová M; Guncová I; Kaiserová H; Palicka V; Ponka P; Gersl V Toxicology; 2007 Jun; 235(3):150-66. PubMed ID: 17459556 [TBL] [Abstract][Full Text] [Related]
29. Chronic heart damage following doxorubicin treatment is alleviated by lovastatin. Henninger C; Huelsenbeck S; Wenzel P; Brand M; Huelsenbeck J; Schad A; Fritz G Pharmacol Res; 2015 Jan; 91():47-56. PubMed ID: 25462173 [TBL] [Abstract][Full Text] [Related]
30. Neuregulin-1 attenuates mitochondrial dysfunction in a rat model of heart failure. Guo YF; Zhang XX; Liu Y; Duan HY; Jie BZ; Wu XS Chin Med J (Engl); 2012 Mar; 125(5):807-14. PubMed ID: 22490579 [TBL] [Abstract][Full Text] [Related]
31. Curcumin induces a nuclear factor-erythroid 2-related factor 2-driven response against oxidative and nitrative stress after praziquantel treatment in liver fluke-infected hamsters. Charoensuk L; Pinlaor P; Prakobwong S; Hiraku Y; Laothong U; Ruangjirachuporn W; Yongvanit P; Pinlaor S Int J Parasitol; 2011 May; 41(6):615-26. PubMed ID: 21256849 [TBL] [Abstract][Full Text] [Related]
32. Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents. Simůnek T; Klimtová I; Kaplanová J; Mazurová Y; Adamcová M; Sterba M; Hrdina R; Gersl V Eur J Heart Fail; 2004 Jun; 6(4):377-87. PubMed ID: 15182761 [TBL] [Abstract][Full Text] [Related]
33. Novel antioxidants in anthracycline cardiotoxicity. Hideg K; Kálai T Cardiovasc Toxicol; 2007; 7(2):160-4. PubMed ID: 17652823 [TBL] [Abstract][Full Text] [Related]
34. α-Tocopherol is an effective Phase II enzyme inducer: protective effects on acrolein-induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells. Feng Z; Liu Z; Li X; Jia H; Sun L; Tian C; Jia L; Liu J J Nutr Biochem; 2010 Dec; 21(12):1222-31. PubMed ID: 20153624 [TBL] [Abstract][Full Text] [Related]
35. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress. Li W; Xu B; Xu J; Wu XL Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):192-7. PubMed ID: 19143757 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress. Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity. Swift L; McHowat J; Sarvazyan N Cancer Res; 2003 Sep; 63(18):5992-8. PubMed ID: 14522926 [TBL] [Abstract][Full Text] [Related]
38. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention. Henriksen PA Heart; 2018 Jun; 104(12):971-977. PubMed ID: 29217634 [TBL] [Abstract][Full Text] [Related]